Heparanase isoform expression and extracellular matrix remodeling in intervertebral disc degenerative disease

Clinics

Volumn 66, Issue 5, 2011, Pages 903-909

  Rodrigues, Luciano Miller Reis ^a   Theodoro, Thérèse Rachell ^a   Matos, Leandro Luongo ^a   Mader, Ana Maria ^a   Milani, Carlo ^a   da Silva Pinhal, Maria Aparecida ^a  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Extracellular matrix; Heparanase; Herniated disc; Intervertebral degeneration; Proteoglycan

Indexed keywords

BETA GLUCURONIDASE; HEPARANASE; ISOENZYME;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYMOLOGY; EXTRACELLULAR MATRIX; HUMAN; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK HERNIA; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; EXTRACELLULAR MATRIX; GLUCURONIDASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISC DEGENERATION; INTERVERTEBRAL DISC DISPLACEMENT; ISOENZYMES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 79960751935     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000500030     Document Type: Article

References (29)

1. Anderson GB. Epidemiology of low back pain. Acta Ortop Scand Suppl. 1990;69:28-31.
2. Mooney V. Where is the lumbar pain coming from? Ann Med. 1989;21:373-9.
3. Battié MC, Videman T, Parent E. Lumbar disc degeneration: epidemiol- ogy and genetic influences. Spine. 2004;29:2679-90.
4. Hassett G, Hart DJ, ManeK NJ, Doyle DV, Spector TD. Risk factors for progression of lumbar spine disc degeneration: the Chingford Study. Arthritis Rheum. 2003;48:3112-7.
5. Robinson D, Mirovsky Y, Halperin N, Evron Z, Nevo Z. Changes in proteoglycans of intervertebral disc in diabetic patients. A possible cause of increased back pain. Spine. 1998;23:849-56.
6. Sambrook PN, MacGregor AJ, Spector TD. Genetic influences on cervical lumbar disc degeneration: a magnetic resonance imaging study in twins. Arthrits Rheum. 1999;42:366-72.
7. Karasek M, Bogduk N. Twelve-month follow-up of a controlled trial of intradiscal thermal anuloplasty for back pain due to internal disc disruption. Spine. 2000;25:2601-7.
8. Lipson SJ, Muir H. Experimental intervertebral disc degeneration: morphologic and proteoglycan changes over time. Arthritis Rheum. 1981;24:12-21.
9. Singh K, Masuda K, Thonar EJ, Ann HS, Cs-Szabo GG. Age-related changes in the extracellular matrix of nucleus pulposus and anulus fibrosus of human intervertebral disc. Spine. 2009;34:10-6.
10. Pearce RH, Grimmer BJ, Adams ME. Degeneration and the chemical composition of the human lumbar intervertebral disc. J Orthop Res. 1987;5:198-205.
11. Gruber HE, Hanley EN Jr. Analysis of aging and degeneration of the human intervertebral disc: comparison of surgical specimens with normal controls. Spine. 1998;23:751-7.
12. Sanderson RD, Yang Y, Suva LJ, Kelly T. Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumor growth and metastasis. Matrix Biol. 2004;23:341-52.
13. Esko JD, Lindahl U. Molecular diversity of heparan sulfato. J Clin Invest. 2001;108:169-73.
14. Vlodavsky I, Goldshmidt O, Zcharia E, Atzmon R, Rangini-Guatta Z, Elkin M, et al. Mammalian heparanase: involvement in cancer metastasis, angiogeneses and normal development. Semin Cancer Biol. 2002;12:121-9.
15. Kram V, Zcharia E, Yacoby-Zeevi O, Metzger S, Chajek-Shaul T, Gabet Y, et al. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J Cell Physiol. 2006;207:784-92.
16. Gomes RR Jr, Van Kuppevelt TH, Farach-Carson MC, Carson DD. Spatiotemporal distribution of heparan sulfato epitopes during murine cartilage growth plate development. Histochem Cell Biol. 2006;126:713-22.
17. Mackenzie E, Tyson K, Stamps A, Smith P, Turner P, Barry R, et al. Cloning and expression profiling of Hpa2, a novel mammalian hepar-anase family member. Biochem Biophys Res Commun. 2000;276:1170-7.
18. Peretti T, Waisberg J, Mader AM, de Matos LL, da Costa RB, Conceição GM, et al. Heparanase-2, syndecan-1, and extracellular matrix remodel- ing in colorectal carcinoma. Eur J Gastroenterol Hepatol. 2008;20:756-65.
19. Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine. 2001;26:1873-8.
20. Matos LL, Stabenow E, Tavares MR, Ferraz AR, Capelozzi VL, Pinhal MA. Immunohistochemistry quantification by a digital computer-assisted method compared to semiquantitative analysis. Clinics. 2006;61:417-24.
21. Pfaffl MW. A new mathematical model for relative quantification in real- time RT-PCR. Nucleic Acids Res. 2001;29:e45.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-8.
23. Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine. 2006;31:2151-61.
24. Iozzo RV. Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol. 2005;6:646-56.
25. Melrose J, Smith S, Ghosh P, Whitelock J. Perlecan, the multidomain heparin sulfate proteoglycan of basement membranes, is also a prominent component of the cartilaginous promordia in the developing human fetal spine. J Histochem Cytochem. 2003;51:1331-41.
26. Brown AJ, Alicknavitch M, D'Souza SS, Daikoku T, Kirn-Safran CB, Marchetti D, et al. Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation. Bone. 2008;43:689-99.
27. Kelly T, Suva LJ, Nicks KM, MacLeod V, Sanderson RD. Tumor- derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis. J Bone Miner Res. 2010;25:1295-304.
28. Yang Y, Macleod V, Miao HQ, Theus A, Zhan F, Shaughnessy JD Jr, et al. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J Biol Chem. 2007;282:13326-33.
29. Elkin M, Cohen I, Zcharia E, Orgel A, Guatta-Rangini Z, Peretz T. Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res. 2003;63:8821-6.